Polymorphisms have been observed also in the gene encoding the EGFR receptor; these have been positively associated with CRC survival in women and negatively in men, highlighting the possibility that the interaction between EGFR and ERβ signaling underlies the differences between the two sexes [10]. The gene discussed is ESR2; the disease is colorectal carcinoma.